Trial
NCT02004392
Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
FORUM Pharmaceuticals Inc
Collaborators
—
Condition
Alzheimer's Disease
Intervention
EVP-6124
Why stopped
Study has been suspended due to clinical hold.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-03